Search by Drug Name or NDC
NDC 73473-0306-30 Clindamycin Phosphate and Tretinoin 10; .25 mg/g; mg/g Details
Clindamycin Phosphate and Tretinoin 10; .25 mg/g; mg/g
Clindamycin Phosphate and Tretinoin is a TOPICAL GEL in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Solaris Pharma Corporation. The primary component is CLINDAMYCIN PHOSPHATE; TRETINOIN.
MedlinePlus Drug Summary
Topical clindamycin is used to treat acne. Clindamycin is in a class of medications called lincomycin antibiotics. It works by slowing or stopping the growth of bacteria that cause acne and by decreasing swelling.
Related Packages: 73473-0306-30Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Clindamycin Topical
Tretinoin (Altreno, Atralin, Avita, Retin-A) is used to treat acne. Tretinoin is also used to reduce fine wrinkles (Refissa and Renova) and to improve spotty discoloration (Renova) and rough feeling skin (Renova) when used along with other skin care and sunlight avoidance programs. Tretinoin is in a class of medications called retinoids. It works by promoting peeling of affected skin areas and unclogging pores.
Related Packages: 73473-0306-30Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Tretinoin Topical
Product Information
| NDC | 73473-0306 |
|---|---|
| Product ID | 73473-306_9d909114-026b-44a8-af8e-82c787b6b584 |
| Associated GPIs | 90059902654020 |
| GCN Sequence Number | 061775 |
| GCN Sequence Number Description | clindamycin/tretinoin GEL (GRAM) 1.2-0.025% TOPICAL |
| HIC3 | L5H |
| HIC3 Description | ACNE AGENTS,TOPICAL |
| GCN | 97560 |
| HICL Sequence Number | 034216 |
| HICL Sequence Number Description | CLINDAMYCIN PHOSPHATE/TRETINOIN |
| Brand/Generic | Generic |
| Proprietary Name | Clindamycin Phosphate and Tretinoin |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | clindamycin phosphate and tretinoin |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | GEL |
| Route | TOPICAL |
| Active Ingredient Strength | 10; .25 |
| Active Ingredient Units | mg/g; mg/g |
| Substance Name | CLINDAMYCIN PHOSPHATE; TRETINOIN |
| Labeler Name | Solaris Pharma Corporation |
| Pharmaceutical Class | Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE], Retinoid [EPC], Retinoids [CS] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA212845 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 73473-0306-30 (73473030630)
| NDC Package Code | 73473-306-30 |
|---|---|
| Billing NDC | 73473030630 |
| Package | 1 TUBE in 1 CARTON (73473-306-30) / 30 g in 1 TUBE |
| Marketing Start Date | 2023-10-19 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 6.5446 |
| Pricing Unit | GM |
| Effective Date | 2024-01-17 |
| NDC Description | CLINDA-TRETINOIN 1.2%-0.025% |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 4, 5 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |